Europe (WHO region) vs Sweden: Estimated antiretroviral therapy coverage among people living with HIV
Europe (WHO region)
67.0%
in 2025
Sweden
95.0%
in 2024
Europe (WHO region) rank
8th
Sweden rank
5th
Estimated antiretroviral therapy coverage among people living with HIV over time
- Europe (WHO region)
- Sweden
How they compare
Sweden currently reports 95.0% against 67.0% in Europe (WHO region), a difference of 28.0%.
That makes Sweden's figure about 1.4 times Europe (WHO region)'s.
Across all 25 years both countries report, Sweden has been ahead every year.
Europe (WHO region) ranks 8th and Sweden ranks 5th of 13 groups.
Sweden has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Europe (WHO region) | Sweden | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 25.3% | 48.8% | 23.5% | Sweden |
| 2010s | 46.4% | 90.8% | 44.4% | Sweden |
| 2020s | 64.6% | 95.8% | 31.2% | Sweden |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher estimated antiretroviral therapy coverage among people living with hiv, Europe (WHO region) or Sweden?
- Sweden, at 95.0% against 67.0% in Europe (WHO region) as of 2024.
- What is the difference in estimated antiretroviral therapy coverage among people living with hiv between Europe (WHO region) and Sweden?
- 28.0%, with Sweden ahead.
- How many years of comparable data are there for Europe (WHO region) and Sweden?
- 25 years are reported by both, from 2000 to 2024.
- How do Europe (WHO region) and Sweden rank globally for estimated antiretroviral therapy coverage among people living with hiv?
- Europe (WHO region) ranks 8th and Sweden ranks 5th of 13 groups.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Estimated antiretroviral therapy coverage among people living with HIV (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.